Scarica l'app Stockscreener
66.40
1.83%
-1.24
Dopo l'orario di chiusura:
66.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$67.64
Aprire:
$67.45
Volume 24 ore:
1.33M
Relative Volume:
0.67
Capitalizzazione di mercato:
$14.77B
Reddito:
$4.03B
Utile/perdita netta:
$556.70M
Rapporto P/E:
28.02
EPS:
2.37
Flusso di cassa netto:
$970.10M
1 W Prestazione:
-2.64%
1M Prestazione:
-2.72%
6M Prestazione:
+7.29%
1 anno Prestazione:
-18.24%
Intervallo 1D:
$66.37
$67.98
Intervallo di 1 settimana:
$64.00
$68.98
Portata 52W:
$51.90
$84.39
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
66.40 | 15.04B | 4.03B | 556.70M | 970.10M | 2.37 |
|
ISRG
Intuitive Surgical Inc
|
443.99 | 160.51B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.05 | 53.46B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
274.19 | 40.35B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
75.00 | 37.18B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
259.94 | 18.03B | 2.96B | 487.70M | 344.00M | 6.68 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Aggiornamento | Argus | Hold → Buy |
| 2025-08-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-27 | Reiterato | Needham | Hold |
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
United States Breast Cancer Diagnostics Industry Intelligence - openPR.com
Is Hologic Stock Underperforming the S&P 500? - MSN
Is Hologic Stock Underperforming The S&P 500? - Barchart.com
HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today? - TradingView
United States Cancer Biopsies Market Poised for Transformative - openPR.com
Pallas Capital Advisors LLC Acquires 1,124 Shares of Hologic, Inc. $HOLX - Defense World
Sumitomo Mitsui DS Asset Management Company Ltd Boosts Stake in Hologic, Inc. $HOLX - Defense World
Blackstone and TPG reignite talks on $15bn-plus Hologic buyout - Private Equity Insights
Hologic Inc. stock trendline breakdownQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com
Hologic (HOLX) Jumps 7.7% on Renewed Billion-Dollar Takeover Bid - MSN
Lumos expands development deal with Hologic for premature birth test - MSN
Aug Mood: Can Hologic Inc reach resistance levels soonEarnings Risk Report & Fast Gaining Stock Strategy Reports - خودرو بانک
Czech National Bank Raises Position in Hologic, Inc. $HOLX - Defense World
What is Zacks Research’s Estimate for Hologic Q2 Earnings? - Defense World
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Market Outlook: Whats the profit margin of Hologic IncMarket Activity Report & Capital Protection Trade Alerts - khodrobank.com
Hologic Extends CEO Stephen MacMillan’s Employment Agreement - TipRanks
Earnings Recap: What are the risks of holding Hologic Inc2025 Dividend Review & Free Long-Term Investment Growth Plans - خودرو بانک
Earnings Recap: How is Hologic Inc managing supply chain issuesJuly 2025 Highlights & Safe Entry Point Identification - خودرو بانک
Argus Research Raises Price Target for Hologic (HOLX) to $90.00 - GuruFocus
Argus Adjusts Price Target on Hologic to $90 From $80 - MarketScreener
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Sentiment Watch: Will Hologic Inc. stock go up in YEARMarket Growth Summary & Long-Term Capital Growth Strategies - خودرو بانک
HOLX Stock Quote Price and Forecast - CNN
Hologic (NASDAQ:HOLX) Receives Overweight Rating from Stephens - Defense World
FY2025 EPS Estimates for Hologic Raised by Zacks Research - Defense World
Blackstone And TPG Return To The Table With Hologic - Finimize
U.S. Oncology Based Molecular Diagnostics Market Trends Analysis Report 2025-2033, Profiles of Abbott, Bayer, BD, Cepheid, Agilent, Danaher, Hologic, Qiagen, F. Hoffmann-La Roche, Siemens, Sysmex - GlobeNewswire
Hologic's Strong International Traction to Continue Despite Headwinds - The Globe and Mail
Endometrial Ablation Devices Market Expected to Expand at 4% - openPR.com
Blackstone and TPG Revive Interest in Acquiring Medtech Hologic - Bloomberg.com
HOLX: Stephens & Co. Reiterates Overweight Rating with Price Tar - GuruFocus
Hologic (HOLX) Soars 7.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Rally Mode: Is Hologic Inc. a cyclical or defensive stock2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - khodrobank.com
Shareholders 17% loss in Hologic (NASDAQ:HOLX) partly attributable to the company's decline in earnings over past year - Yahoo Finance
United States Mammography Machine Market Growth Driven - openPR.com
Aesthetic Medicine Market to See Booming Growth 2025-2032 | Alma Laser, Hologic, Inc. (Cynosure) - openPR.com
Voya Investment Management LLC Sells 13,515 Shares of Hologic, Inc. $HOLX - Defense World
Hologic, Inc. $HOLX Shares Sold by First Hawaiian Bank - MarketBeat
United Services Automobile Association Takes $347,000 Position in Hologic, Inc. $HOLX - MarketBeat
Strs Ohio Takes Position in Hologic, Inc. $HOLX - MarketBeat
Hologic (NASDAQ:HOLX) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $138.70 Million Position in Hologic, Inc. $HOLX - MarketBeat
Swedbank AB Trims Position in Hologic, Inc. $HOLX - MarketBeat
Trend Report: Is Hologic Inc a cyclical or defensive stockJuly 2025 Market Mood & Community Consensus Trade Signals - خودرو بانک
Blackstone and TPG revive interest in buying Hologic, source says - MarketScreener
Hologic Stock Soars After Blackstone, TPG Reportedly Revive Takeover Interest - MarketScreener
Hologic (HOLX) Shares Surge Following Private Equity Interest - GuruFocus
Stock Movers: StubHub, Workday, Hologic - Bloomberg.com
Blackstone, TPG Restart Discussions to Acquire Hologic - MarketScreener
Blackstone (BX) Reconsiders Hologic Acquisition - GuruFocus
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.26%
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):